Td Private Client Wealth LLC United Therapeutics Corp Transaction History

Td Private Client Wealth LLC

  • $4.07 Trillion
  • Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Td Private Client Wealth LLC holds 4,672 shares of UTHR stock, worth $2.07 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,672
Previous 4,762 1.89%
Holding current value
$2.07 Million
Previous $1.47 Billion 8.55%
% of portfolio
0.03%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025
SELL
$276.47 - $328.4 $24,882 - $29,555
-90 Reduced 1.89%
4,672 $1.34 Billion
Q1 2025

Apr 29, 2025
BUY
$304.42 - $380.78 $332,426 - $415,811
1,092 Added 29.75%
4,762 $1.47 Billion
Q4 2024

Feb 11, 2025
SELL
$348.66 - $410.0 $6,275 - $7,380
-18 Reduced 0.49%
3,670 $1.29 Billion
Q3 2024

Nov 18, 2024
BUY
$311.04 - $363.55 $111,352 - $130,150
358 Added 10.75%
3,688 $1.32 Billion
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $760,105 - $1.06 Million
3,330 New
3,330 $1.06 Billion
Q1 2024

Aug 16, 2024
BUY
$210.76 - $249.51 $28,452 - $33,683
135 Added 4.26%
3,304 $759 Million
Q4 2023

Aug 16, 2024
SELL
$214.88 - $256.94 $29,868 - $35,714
-139 Reduced 4.2%
3,169 $697 Million
Q3 2023

Aug 16, 2024
SELL
$211.82 - $248.24 $176,657 - $207,032
-834 Reduced 20.14%
3,308 $747 Million
Q2 2023

Aug 16, 2024
SELL
$205.19 - $232.99 $50,887 - $57,781
-248 Reduced 5.65%
4,142 $914 Million
Q1 2023

Aug 16, 2024
SELL
$212.99 - $276.17 $59,850 - $77,603
-281 Reduced 6.02%
4,390 $983 Million
Q4 2022

Aug 16, 2024
SELL
$205.95 - $280.43 $246,522 - $335,674
-1,197 Reduced 20.4%
4,671 $1.3 Billion
Q3 2022

Aug 16, 2024
SELL
$203.3 - $244.17 $37,000 - $44,438
-182 Reduced 3.01%
5,868 $1.23 Billion
Q2 2022

Aug 16, 2024
SELL
$174.81 - $241.14 $135,827 - $187,365
-777 Reduced 11.38%
6,050 $1.43 Billion
Q1 2022

Aug 16, 2024
BUY
$166.16 - $213.96 $165,827 - $213,532
998 Added 17.12%
6,827 $1.22 Billion
Q4 2021

Aug 16, 2024
SELL
$184.32 - $216.08 $451,215 - $528,963
-2,448 Reduced 29.58%
5,829 $1.26 Billion
Q3 2021

Aug 16, 2024
BUY
$179.86 - $214.88 $889,767 - $1.06 Million
4,947 Added 148.56%
8,277 $1.53 Billion
Q4 2020

Aug 16, 2024
SELL
$101.87 - $151.79 $1,528 - $2,276
-15 Closed
0 $0
Q4 2019

Aug 16, 2024
SELL
$78.31 - $95.34 $259,597 - $316,052
-3,315 Reduced 99.55%
15 $1.32 Million

Others Institutions Holding UTHR

# of Institutions
745
Shares Held
44.1M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $20.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email